Variable | Study group (411) | All patients (1006) | P value (χ2 test) |
---|---|---|---|
Gender (man) | 74.7% (307) | 75.2% (757) | 0.736 |
Age (mean) | 39.36 (411) | 39.85 (1006) | Â |
Medication | |||
 Methadone | 53.3% (219) | 51.6% (519) | 0.628 |
 Buprenorphine | 27.3% (112) | 28.7% (289) |  |
 Buprenorphine/naloxone | 19.5% (80) | 19.7% (198) |  |
Dose (mg) | |||
 Methadone | 99.32 (219) | 98.55 (517) |  |
 Mono-buprenorphine | 19.02 (112) | 19.44 (289) |  |
 Buprenorphine/naloxone | 18.78 (80) | 18.88 (198) |  |
Pick-up routines | |||
 5–7 days/week | 34.5% (142) | 21.4% (215) | 0.000 |
 2–4 days/week | 36.3% (149) | 35.8% (360) |  |
 More seldom | 29.2% (120) | 42.8% (431) |  |